Risk of progression of cervical intraepithelial neoplasia grade 2 by HPV vaccination status

被引：0
|
作者：
Krog, Louise [1 ,2 ,3 ]
Lycke, Kathrine Dyhr [1 ,2 ,3 ]
Kahlert, Johnny [4 ]
Randrup, Tina [1 ]
Jensen, Pernille Tine [3 ,5 ]
Rositch, Anne [4 ]
Hammer, Anne [1 ,2 ,3 ]
机构：
[1] Godstrup Hosp, Dept Obstet & Gynecol, Herning, Denmark
[2] Godstrup Hosp, NIDO Ctr Res & Educ, Herning, Denmark
[3] Aarhus Univ, Dept Clin Med, Aarhus, Denmark
[4] Johns Hopkins Bloomberg Sch Publ Hlth, Dept Epidemiol, Baltimore, MD USA
[5] Aarhus Univ Hosp, Dept Obstet & Gynecol, Aarhus, Denmark
来源：
ACTA OBSTETRICIA ET GYNECOLOGICA SCANDINAVICA | 2023年 / 102卷
关键词：
D O I：
暂无
中图分类号：
R71 [妇产科学];
学科分类号：
100211 ;
摘要：
引用
收藏
页码：67 / 67
页数：1
相关论文
共 50 条
  • [1] Risk of cervical intraepithelial neoplasia grade 2 or worse after conization in relation to HPV vaccination status
    Sand, Freja L.
    Kjaer, Susanne K.
    Frederiksen, Kirsten
    Dehlendorff, Christian
    INTERNATIONAL JOURNAL OF CANCER, 2020, 147 (03) : 641 - 647
  • [2] HPV, histologic grade and age - Risk factors for the progression of cervical intraepithelial neoplasia
    Konno, R
    Paez, C
    Sato, S
    Yajima, A
    Fukao, A
    JOURNAL OF REPRODUCTIVE MEDICINE, 1998, 43 (07) : 561 - 566
  • [3] HPV 16 Is Related to the Progression of Cervical Intraepithelial Neoplasia Grade 2: A Case Series
    Loffredo D'Ottaviano, Maria Gabriela
    Discacciati, Michelle Garcia
    Andreoli, Maria Antonieta
    Costa, Maria Cecelia
    Termini, Lara
    Rabelo-Santos, Silvia H.
    Villa, Luisa Lina
    Zeferino, Luiz Carlos
    OBSTETRICS AND GYNECOLOGY INTERNATIONAL, 2013, 2013
  • [4] HPV Vaccination for the Prevention of Cervical Intraepithelial Neoplasia
    Kahn, Jessica A.
    NEW ENGLAND JOURNAL OF MEDICINE, 2009, 361 (03): : 271 - 278
  • [5] Cervical intraepithelial neoplasia grade 2 or worse in Galicia, Spain: HPV 16 prevalence and vaccination impact
    Perez-Castro, Sonia
    Lorenzo-Mahia, Yolanda
    Inarrea Fernandez, Amparo
    Jose Lamas-Gonzalez, Maria
    Teresa Saran-Diez, Maria
    Rubio-Alarcon, Joaquin
    Consuelo Reboredo-Reboredo, Maria
    Mosteiro-Lobato, Sonia
    Lopez-Miragaya, Isabel
    Torres-Pinon, Julio
    Melon-Garcia, Santiago
    ENFERMEDADES INFECCIOSAS Y MICROBIOLOGIA CLINICA, 2014, 32 (08): : 479 - 485
  • [6] Regression and progression rates of untreated cervical intraepithelial neoplasia grade 2
    Lycke, Kathrine Dyhr
    Kahlert, Johnny
    Damgaard, Rikke Kamp
    Eriksen, Dina Overgaard
    Bennetsen, Mary Holten
    Petersen, Lone Kjeld
    Gravitt, Patti
    Hammer, Anne
    ACTA OBSTETRICIA ET GYNECOLOGICA SCANDINAVICA, 2023, 102 : 80 - 80
  • [7] Duration of HPV-associated risk for high-grade cervical intraepithelial neoplasia
    Hernadi, Zoltan
    Gazdag, Laszlo
    Szoke, Krisztina
    Sapy, Tamas
    Krasznai, Zoard T.
    Konya, Jozsef
    EUROPEAN JOURNAL OF OBSTETRICS & GYNECOLOGY AND REPRODUCTIVE BIOLOGY, 2006, 125 (01) : 114 - 119
  • [8] Cervical intraepithelial neoplasia in women who had vaccination against HPV
    Bogani, Giorgio
    Serati, Maurizio
    Maggiore, Umberto L. R.
    Ditto, Antonino
    Gardella, Barbara
    Ferrero, Simone
    Spinillo, Arsenio
    Ghezzi, Fabio
    Raspagliesi, Francesco
    INTERNATIONAL JOURNAL OF GYNECOLOGY & OBSTETRICS, 2019, 147 (02) : 233 - 237
  • [9] HPV vaccination after treatment of cervical intraepithelial neoplasia (CIN/HSIL)
    Dannecker, Christian
    GYNAKOLOGE, 2021, 54 (11): : 816 - 819
  • [10] The HPV E4 is a candidate biomarker in cervical intraepithelial neoplasia grade 2
    Murakami, Isao
    Chiyokura, Ryoko
    Shimada, Sayaki
    Tanaka, Kyoko
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2023, 33 (SUPPL_4) : A107 - A108
12345